The FDA has approved Shionogi's Xocova (ensitrelvir) for post-exposure prevention of Covid-19 in adults and adolescents aged ...
FDA approves Shionogi’s Xocova as First Oral Post-Exposure Covid-19 Prevention Therapy, marking a major milestone for Covid-19 prevention treatments. FDA has approved Shionogi’s Xocova (ensitrelvir) ...
The FDA on Monday approved the first medication for COVID-19 prevention that people can take after they have been exposed to ...
The Centers for Disease Control and Prevention on Monday said it had officially recommended updated coronavirus vaccines, creating a new system to get a shot that’s slightly more complicated than in ...
A top U.S. health official on Monday called for the combined measles-mumps-rubella shot to be broken up, drawing a quick rebuke from vaccine maker Merck, which said there is no scientific evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results